These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6843332)

  • 1. [The value of urine cytology in the diagnosis of primary and recurrent urotheliomas].
    Truss F
    Med Welt; 1983 Mar; 34(11):337-41. PubMed ID: 6843332
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of urine phosphohexose isomerase activity in comparison with urine cytology. First diagnosis and tumor after-care in patients with cancer of the urinary bladder].
    Voigt W; Rothauge CF; Schäffer R
    Urologe A; 1994 May; 33(3):235-42. PubMed ID: 8053092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
    Möllhoff S; Rathert P
    Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
    [No Abstract]   [Full Text] [Related]  

  • 5. What's the trouble with cytology?
    Murphy WM
    J Urol; 2006 Dec; 176(6 Pt 1):2343-6. PubMed ID: 17085097
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine cytology in the detection of bladder tumor recurrence.
    Orandi A; Orandi M
    J Urol; 1976 Nov; 116(5):568-9. PubMed ID: 978807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?
    Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL;
    Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of urine cytology in the diagnosis of recurrent bladder tumors. A preliminary report.
    reichborn-Kjennerud S; Hoeg K
    Acta Cytol; 1972; 16(3):269-72. PubMed ID: 4503072
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary cytology. Possibilities, limitations and the future].
    Zaak D; Tritschler S; Knuechel R; Vom Dorp F; Hakenberg OW; Hautmann S; Rübben H
    Urologe A; 2006 Sep; 45 Suppl 4():97-101. PubMed ID: 16821054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary cytology in symptomatic subjects: cyto-histological comparison in 124 cases].
    Pisa R; Piubello Q; Scarpa A; Novelli P; Baiocco R; Pea M; Marino F
    Pathologica; 1985; 77(1050):409-16. PubMed ID: 3834373
    [No Abstract]   [Full Text] [Related]  

  • 14. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant pheochromocytoma of the urinary bladder. Case report and review of the literature].
    Stein R; Steinbach F; Voges GE; Müller SC; Störkel S; Bockisch A; Derschum W; Hohenfellner R
    Urologe A; 1993 Nov; 32(6):497-502. PubMed ID: 8284863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The BTA stat test in the follow-up for bladder cancer].
    Gutiérrez Baños JL; Martín García B; de Diego Rodríguez E; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; del Valle Schaan JI; Roca Edreira A; Rado Velázquez MA
    Arch Esp Urol; 1999 Oct; 52(8):856-61. PubMed ID: 10589117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ImmunoCyt--a new urine test in diagnosis of bladder cancer].
    Feil G; Bichler KH; Päulgen-Nelde HJ; Hennenlotter J; Zumbrägel A; Stenzl A
    Urologe A; 2003 Apr; 42(4):531-7. PubMed ID: 12715125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early diagnosis of (recurring) bladder cancer by cytology].
    Studer UE; Antonelli M; Kraft R
    Helv Chir Acta; 1982 Aug; 49(3-4):317-20. PubMed ID: 7129895
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.